Feature

Thousands of patients were implanted with heart pumps that the FDA knew could be dangerous


 

“Run its course”

Deserae Cain, 33, is one of the 4,000 patients still relying on a HeartWare device.

She was implanted with the heart pump in late 2017, after suddenly being diagnosed with heart failure. Scans showed her heart was three times normal size. It took time for her to come to terms with needing a life-sustaining device — not long before her diagnosis, she had been going on five-mile runs. In the four years since, though, Cain has built a life around the HVAD with her fiance in their Dayton, Ohio, home.

They know the device can malfunction. In 2019, the pump failed for almost an hour as doctors at a nearby hospital struggled to restart it. Cain just tried to stay calm, knowing anxiety could threaten her unsupported weak heart. Months later, she needed an emergency experimental procedure to clear out blood clots developed within her HVAD.

Then, in 2020, Cain developed a widespread infection. Doctors told her she needed surgery to clean out and replace the pump.

Cain asked her medical team if she could switch to the alternative HeartMate device, which other patients told her presented fewer problems, she said. Doctors said the HVAD was better suited for her smaller frame.

But her new pump had problems soon after the surgery.

The device’s suction alarms, which alert when the pump is trying to pull in more blood than is available within the heart, sounded multiple times a day, for hours at a time, she said. Baffled by the issue for months, her medical team eventually turned off that specific alarm.

Soon after, her ventricular-assist specialist called her about a patient’s death linked to the belt that holds the device controller, she said. The belt had ripped and the equipment had fallen, yanking on the cable that connected the controller to the pump. Cain replaced her belt but it quickly frayed and had to be replaced again within six weeks.

Then, in June, she found out about Medtronic’s decision to stop sales and implants. Cain received a letter from her hospital mentioning a Medtronic support program, but it provided few specifics.

Cain wondered if things would be any different than before. Anxious about her future, she asked: “Are they just going to let it run its course until there is none of us left?”

This article first appeared on Propublica.

Pages

Recommended Reading

Meta-analysis supports cardiovascular benefits of EPA
MDedge Family Medicine
St. Jude to pay $27 million to end DOJ suit over faulty ICDs
MDedge Family Medicine
Cycling linked to longer life in people with type 2 diabetes
MDedge Family Medicine
Dapagliflozin safe, protective in advanced kidney disease
MDedge Family Medicine
Rising meth-related heart failure admissions a ‘crisis,’ costly for society
MDedge Family Medicine
Diabetes duration linked to increasing heart failure risk
MDedge Family Medicine
In sickness and in health: Spouses can share risk for cardiac events
MDedge Family Medicine
ESC heart failure guideline to integrate bounty of new meds
MDedge Family Medicine
Even 10 minutes of daily exercise beneficial after ICD implantation
MDedge Family Medicine
How heat kills: Deadly weather ‘cooking’ people from within
MDedge Family Medicine